Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
K
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Keshav Garg's research has investigated various aspects of public health and clinical outcomes. His work includes a cross-sectional study on medication adherence and its predictors among patients with Type 2 Diabetes Mellitus, and an examination of prescription patterns for oral antidiabetic agents in Punjab. Garg has also contributed to research on COVID-19, including a study on convalescent plasma donors and the psychological assessment of family caregivers of patients with the virus. Additional publications explore the characteristics and outcomes of differentiated thyroid cancers treated with tyrosine kinase inhibitors, and a comparison of mobilization regimens for peripheral blood stem cell mobilization in Hodgkin lymphoma. His research interests also extend to cardiovascular complications in RASopathies and the prevalence of hypertension in young adults.
Metrics
- h-index: 2
- Publications: 5
- Citations: 75
Selected Publications
-
An Update of Oxidative Stress in Atherosclerosis with Emphasis on the LOX-1–NLRP3 Inflammasome Axis (2026)
-
Peri-Procedural Ischemic Stroke in Patients Undergoing Ventricular Tachycardia Ablation: Incidence, Predictors, and Impact on Mortality (2026)
-
POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
-
CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
-
AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review (2026)
-
Cardiovascular outcomes of durvalumab versus pembrolizumab in gastric cancer: A propensity-matched TriNetX analysis. (2026)
-
Predictors and Outcomes of Pulmonary Embolism After Coronary Artery Bypass Grafting (2026)
-
26-A-21124-ACC PREDICTORS OF MYOCARDIAL RECOVERY IN HEART FAILURE WITH REDUCED EJECTION FRACTION (2026)
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)
-
Contemporary Review of Clinical Features, Multi-Modality Imaging, and Management of Pericardial Cysts (2026)
-
Functional Biochemistry of Iron and Its Cardiopulmonary Impact (2026)
Collaboration Network
Top Collaborators
Ankit Agrawal
University of Arkansas for Medical Sciences
4 shared publications
In database
- Contemporary Review of Clinical Features, Multi-Modality Imaging, and Management of Pericardial Cysts
- Predictors and Outcomes of Pulmonary Embolism After Coronary Artery Bypass Grafting
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
- Peri-Procedural Ischemic Stroke in Patients Undergoing Ventricular Tachycardia Ablation: Incidence, Predictors, and Impact on Mortality
Bhupendar Tayal
University of Arkansas for Medical Sciences
4 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- 26-A-21124-ACC PREDICTORS OF MYOCARDIAL RECOVERY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Vidhi Bhanushali
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cardiovascular outcomes of durvalumab versus pembrolizumab in gastric cancer: A propensity-matched TriNetX analysis.
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
- CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
- POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
Nitesh Gautam
University of Arkansas for Medical Sciences
3 shared publications
In database
- Functional Biochemistry of Iron and Its Cardiopulmonary Impact
- 26-A-21124-ACC PREDICTORS OF MYOCARDIAL RECOVERY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Robert Spraggins
University of Arkansas for Medical Sciences
3 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Landon Bruich
University of Arkansas for Medical Sciences
3 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Buthainah Alhwarat
University of Arkansas for Medical Sciences
3 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Akiva Rosenzveig
Cleveland Clinic (US)
2 shared publications
- Contemporary Review of Clinical Features, Multi-Modality Imaging, and Management of Pericardial Cysts
- Predictors and Outcomes of Pulmonary Embolism After Coronary Artery Bypass Grafting
Khalid Sawalha
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Aakash Rana
Central Arkansas Veterans Healthcare System (US)
2 shared publications
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review
Brad Fugere
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Tripti Shukla
University of Arkansas for Medical Sciences
2 shared publications
In database
- 1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
Urveesh Sharma
University of Arkansas for Medical Sciences
2 shared publications
In database
- CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
- POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
Arnav Lakkimsetti
University of Arkansas for Medical Sciences
2 shared publications
In database
- CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
- POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
Rhytha Kasiraj
University of Arkansas for Medical Sciences
2 shared publications
In database
- CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
- POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity
Similar Researchers
Based on overlapping research topics
Nephertiti Efeovbokhan
Arkansas State University
Diabetes Management and Research
Health disparities and outcomes
Cardiovascular Function and Risk Factors
Clare C. Brown
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Health disparities and outcomes
Cardiovascular Function and Risk Factors
Mario Schootman
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Health disparities and outcomes
Cancer Treatment and Pharmacology
Soichiro Takashashi
Arkansas State University
SARS-CoV-2 and COVID-19 Research
Cardiovascular Function and Risk Factors
Public Health Research
E Park
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Health disparities and outcomes
Cardiovascular Function and Risk Factors
Priyanka Rani Saha
Arkansas State University
Diabetes Management and Research
Health disparities and outcomes
Public Health Research